Literature DB >> 23098153

Mortality prediction in Chagas heart disease.

Maria Carmo Pereira Nunes1, Andre Assis Lopes do Carmo, Manoel Otávio Costa Rocha, Antonio Luiz Ribeiro.   

Abstract

Chagas disease continues to be an important cause of cardiac disease in many countries of Latin America. Dilated cardiomyopathy constitutes the more severe manifestation and main cause of death in the disease. Typical clinical presentations include three basic syndromes: heart failure, cardiac arrhythmia and thromboembolism. The identification of markers related to the progression of Chagas heart disease is relevant for appropriate patient management. The most important predictors of death are New York Heart Association functional class, left ventricular systolic dysfunction and nonsustained ventricular tachycardia, which reflect the severity of myocardial damage. Several other potential prognostic factors have recently been reported. Scores for mortality prediction using a combination of prognostic variables have contributed to overall improvement in risk stratification in the setting of Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098153     DOI: 10.1586/erc.12.111

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  12 in total

1.  The prognostic value of health-related quality of life in patients with Chagas heart disease.

Authors:  Henrique Silveira Costa; Márcia Maria Oliveira Lima; Pedro Henrique Scheidt Figueiredo; Ana Thereza Chaves; Maria Carmo Pereira Nunes; Manoel Otávio da Costa Rocha
Journal:  Qual Life Res       Date:  2018-08-30       Impact factor: 4.147

Review 2.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

3.  Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi-Seropositive Individuals.

Authors:  Maria Carmo P Nunes; Lewis F Buss; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Jose Luiz P Silva; Larissa Natany A Martins; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Bruno Oliveira de Figueiredo Brito; Ariela Mota Ferreira; Lea Campos Oliveira; Ana Luiza Bierrenbach; Fabio Fernandes; Michael P Busch; Viviane Tiemi Hotta; Luiz Mario Baptista Martinelli; Maria Carolina F Almeida Soeiro; Adriana Brentegani; Vera M C Salemi; Marcia M Menezes
Journal:  Circulation       Date:  2021-09-27       Impact factor: 29.690

4.  Pathogenesis of chagas cardiomyopathy: role of inflammation and oxidative stress.

Authors:  Fabiana S Machado; Herbert B Tanowitz; Antonio L Ribeiro
Journal:  J Am Heart Assoc       Date:  2013-10-23       Impact factor: 5.501

5.  Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy.

Authors:  Henrique S Costa; Marcia Maria O Lima; Pedro Henrique S Figueiredo; Patrícia M Martinelli; Elizabeth Rs Camargos; Ana Thereza Chaves; Maria Carmo Pereira Nunes; Manoel Otavio C Rocha
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-08-20       Impact factor: 2.743

6.  Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy.

Authors:  Luis E Echeverría; Sergio Alejandro Gómez-Ochoa; Lyda Z Rojas; Karen Andrea García-Rueda; Pedro López-Aldana; Taulant Muka; Carlos A Morillo
Journal:  Front Cardiovasc Med       Date:  2021-11-29

7.  The health-related quality of life in patients with Chagas disease: the state of the art.

Authors:  Igor Lucas Geraldo Izalino de Almeida; Luciano Fonseca Lemos de Oliveira; Pedro Henrique Scheidt Figueiredo; Rafael Dias de Brito Oliveira; Thayrine Rosa Damasceno; Whesley Tanor Silva; Lucas Frois Fernandes de Oliveira; Matheus Ribeiro Ávila; Vanessa Pereira Lima; Ana Thereza Chaves Lages; Mauro Felippe Felix Mediano; Manoel Otávio Costa Rocha; Henrique Silveira Costa
Journal:  Rev Soc Bras Med Trop       Date:  2022-03-14       Impact factor: 1.581

8.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

9.  Heart rate recovery in asymptomatic patients with Chagas disease.

Authors:  Maria Clara Noman de Alencar; Manoel Otávio da Costa Rocha; Márcia Maria de Oliveira Lima; Henrique Silveira Costa; Giovane Rodrigo Sousa; Renata de Carvalho Bicalho Carneiro; Guilherme Canabrava Rodrigues Silva; Fernando Vieira Brandão; Lucas Jordan Kreuser; Antonio Luiz Pinho Ribeiro; Maria Carmo Pereira Nunes
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

10.  Risk Score for Predicting 2-Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi-Trop Cohort Study.

Authors:  Claudia Di Lorenzo Oliveira; Maria Carmo P Nunes; Enrico Antonio Colosimo; Emilly Malveira de Lima; Clareci S Cardoso; Ariela Mota Ferreira; Lea Campos de Oliveira; Carlos Henrique Valente Moreira; Ana Luiza Bierrenbach; Desireé Sant Ana Haikal; Sérgio Viana Peixoto; Maria Fernanda Lima-Costa; Ester Cerdeira Sabino; Antonio Luiz P Ribeiro
Journal:  J Am Heart Assoc       Date:  2020-03-11       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.